Hynic-toc

CAT: 0804-HY-P10232Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-P10232Size:1 Each
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Hynic-toc (HYNIC-Tyr3-octreotide), a octreotide derivative, can be conjugated with radioactive element for tumor imaging[1]. Hynic-toc can be used for the synthesis/research of Radionuclide-Drug Conjugates (RDCs) .
CAS Number
[257943-19-4]
Product Name Alternative
HYNIC-Tyr3-octreotide
UNSPSC
12352209
Target
Radionuclide-Drug Conjugates (RDCs)
Type
Peptides
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hynic-toc.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H](NC([C@H](CSSC[C@H](NC([C@](NC([C@@H](NC1=O)CCCCN)=O)([H])[C@H](O)C)=O)C(N[C@H](CO)[C@H](O)C)=O)NC([C@H](NC(C(C=C/2)=CNC2=N\N)=O)CC3=CC=CC=C3)=O)=O)CC4=CC=C(C=C4)O)N[C@@H]1CC5=CNC6=CC=CC=C56
Molecular Formula
C55H71N13O12S2
Molecular Weight
1170.36
References & Citations
[1]Decristoforo C, et al. 99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours; first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives. Eur J Nucl Med. 2000 Sep;27 (9) :1318-25.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported

Popular Products